Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |